Evidence map›Paper›PMID 35834058›Full record

ArticleNeurotoxicity research2022

4'-Iodo-α-Pyrrolidinononanophenone Provokes Differentiated SH-SY5Y Cell Apoptosis Through Downregulating Nitric Oxide Production and Bcl-2 Expression.

Yuji Sakai, Yoshifumi Morikawa, Yukino Nagao, Junta Hattori, Koichi Suenami, Emiko Yanase, Tomohiro Takayama, Akira Ikari, Toshiyuki Matsunaga

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuji SakaiForensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, 500-8501, Japan. yujsakai1115@gmail.com.
Yoshifumi MorikawaForensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, 500-8501, Japan.
Yukino NagaoLaboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu, 502-8585, Japan.
Junta HattoriLaboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu, 502-8585, Japan.
Koichi SuenamiForensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, 500-8501, Japan.
Emiko YanaseFaculty of Applied Biological Sciences, Gifu University, Gifu, 501-1112, Japan.
Tomohiro TakayamaForensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, 500-8501, Japan.
Akira IkariLaboratory of Biochemistry, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
Toshiyuki MatsunagaLaboratory of Bioinformatics, Gifu Pharmaceutical University, Gifu, 502-8585, Japan.
Gifu Pharmaceutical University · JPGifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abuse of pyrrolidinophenone derivatives (PPs) is known to cause severe damage to the central nervous system due to their high lipophilicity. In this study, we compared sensitivity to toxicity elicited by 4'-iodo-α-pyrrolidinononanophenone (I-α-PNP), one of the most potent cytotoxic derivatives among PPs synthesized previously, between SH-SY5Y cells differentiated by all-trans-retinoic acid (ATRA) and the undifferentiated cells, and found that the differentiated cells are more sensitive to I-α-PNP toxicity than the undifferentiated cells. Treatment with I-α-PNP elicited some apoptotic alterations (Bax expression, loss of mitrochondrial membrane potential, and activation of caspases) in the differentiated cells, whose patterns were similar to those in the undifferentiated cells. I-α-PNP treatment resulted in no significant alteration in Bcl-2 expression in the undifferentiated cells, whereas it considerably downregulated the protein expression in the differentiated cells, suggesting that the high I-α-PNP sensitivity of the differentiated cells is mainly due to downregulation of Bcl-2 expression. I-α-PNP treatment decreased nitric oxide (NO) production and neuronal NOS (nNOS) expression in the differentiated cells, and the patterns of I-α-PNP-evoked alterations in phosphorylation of cAMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) expression were almost the same as that in nNOS expression. Additionally, the addition of an NO donor restored the I-α-PNP-evoked alterations in expressions of Bcl-2, BDNF, and nNOS in the differentiated cells. These findings suggest that the downregulation of Bcl-2 expression by I-α-PNP in differentiated cells is attributed to the acceleration of two negative feedback loops (nNOS/NO/CREB loop and CREB/BDNF loop) triggered by decreased NO production.

Indexed as

Brain-Derived Neurotrophic FactorNeuroblastomaApoptosisbcl-2-Associated X ProteinCaspasesCell Line, TumorCyclic AMP Response Element-Binding ProteinHumansKetonesNitric OxidePyrrolidinesTretinoinalpha-pyrrolidinononanophenonebcl-2-Associated X ProteinBrain-Derived Neurotrophic FactorCaspasesCyclic AMP Response Element-Binding ProteinKetonesNitric OxidePyrrolidinesTretinoin4′-Iodo-α-pyrrolidinononanophenoneBrain-derived neurotrophic factorHuman neuronal SH-SY5Y cellMitochondrial dysfunctionNitric oxide synthasePyrrolidinophenones

Identifiers

PMID35834058
OpenAlexW4285387792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.